{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:37:21Z","timestamp":1794253041351,"version":"4.9.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.05.001","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T17:20:28Z","timestamp":1243617628000},"page":"B42-B50","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S2","title":["Meningococcal protein antigens and vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"Ian M.","family":"Feavers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.vaccine.2005.07.084","article-title":"Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?","volume":"24","author":"Stein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.001_bib2","doi-asserted-by":"crossref","unstructured":"Holst J, Martin D, Arnold R, Campa Huergo C, Oster P, O\u2019Hallahan J, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine; this issue.","DOI":"10.1016\/j.vaccine.2009.04.071"},{"issue":"8775","key":"10.1016\/j.vaccine.2009.05.001_bib3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib4","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2807\/esm.11.07.00635-en","article-title":"Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005","volume":"11","author":"Rouaud","year":"2006","journal-title":"Euro Surveill"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.05.001_bib6","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2005.01.061","article-title":"From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib7","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/pmic.200500502","article-title":"Outer membrane vesicles of the VA-MENGOC-BC(R) vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry","volume":"6","author":"Uli","year":"2006","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib8","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2009.05.001_bib9","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.001_bib10","article-title":"Immunogenicty and reactogenicity of a novel serogroup B Neisseria meningitidis vaccine administered from 6 months of age","volume":"Rotterdam, The Netherlands","author":"Snape","year":"2008","journal-title":"16th international pathogenic Neisseria conference"},{"key":"10.1016\/j.vaccine.2009.05.001_bib11","series-title":"Handbook of meningococcal disease","first-page":"17","article-title":"The population biology of Neisseria meningitidis: implications for meningococcal disease, epidemiology and control","author":"Maiden","year":"2006"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitides","volume":"106","author":"Caugant","year":"1998","journal-title":"APMIS"},{"issue":"6777","key":"10.1016\/j.vaccine.2009.05.001_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35006655","article-title":"Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491","volume":"404","author":"Parkhill","year":"2000","journal-title":"Nature"},{"issue":"5459","key":"10.1016\/j.vaccine.2009.05.001_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"6777","key":"10.1016\/j.vaccine.2009.05.001_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/35006546","article-title":"ABC of meningococcal diversity","volume":"404","author":"Feavers","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib16","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/IAI.72.10.5955-5962.2004","article-title":"Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design","volume":"72","author":"Urwin","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib17","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.pgen.0030023","article-title":"Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18","volume":"3","author":"Bentley","year":"2007","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/7.4.504","article-title":"Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes","volume":"7","author":"Frasch","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2958.1998.01101.x","article-title":"A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae","volume":"30","author":"Feavers","year":"1998","journal-title":"Mol Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib20","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane proteins in pathogenic Neisseria species","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.171.6.1871","article-title":"Deduced amino acid sequences of class 1 protein PorA from three strains of Neisseria meningitidis","volume":"171","author":"McGuinness","year":"1990","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2958.1991.tb00743.x","article-title":"Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis","volume":"5","author":"Maiden","year":"1991","journal-title":"Mol Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib23","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/IAI.60.9.3620-3629.1992","article-title":"Molecular analysis of the serotyping antigens of Neisseria meningitidis","volume":"60","author":"Feavers","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.001_bib24","series-title":"Handbook of meningococcal disease","first-page":"37","article-title":"Methods for typing meningococci","author":"Jolley","year":"2006"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/IAI.58.5.1355-1359.1990","article-title":"Isolation of Neisseria meningitidis mutants deficient in Class 1 (PorA) and Class 3 (PorB) outer membrane proteins","volume":"58","author":"Tommassen","year":"1990","journal-title":"Infect Immun"},{"issue":"39","key":"10.1016\/j.vaccine.2009.05.001_bib26","doi-asserted-by":"crossref","first-page":"25329","DOI":"10.1074\/jbc.273.39.25329","article-title":"Characterization of the structure, function, and conformational stability of PorB class 3 protein from Neisseria meningitides. A porin with unusual physicochemical properties","volume":"273","author":"Minetti","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.05.001_bib27","series-title":"11th pathogenic Neisseria conference","article-title":"Meningococcal PorA Class 1 proteins exist in nature as a heterotrimeric porin with PorB proteins","author":"Minetti","year":"1998"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0005-2736(00)00155-3","article-title":"Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis","volume":"1464","author":"Jansen","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/pmic.200800486","article-title":"Analysis of outer membrane porin complexes of Neisseria meningitidis in wild-type and specific knock-out mutant strains","volume":"9","author":"Marzoa","year":"2009","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib31","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.001_bib32","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib33","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/IAI.66.7.3223-3231.1998","article-title":"Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial","volume":"66","author":"Wedege","year":"1998","journal-title":"Infect Immun"},{"issue":"23","key":"10.1016\/j.vaccine.2009.05.001_bib34","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0264-410X(00)00047-5","article-title":"Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine","volume":"18","author":"Martin","year":"2000","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.05.001_bib35","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib36","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.71.4.1650-1655.2003","article-title":"Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine","volume":"71","author":"Vermont","year":"2003","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.vaccine.2009.05.001_bib37","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.vaccine.2006.09.025","article-title":"Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs","volume":"25","author":"van den Dobbelsteen","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0966-842X(02)00037-9","article-title":"The role of porins in neisserial pathogenesis and immunity","volume":"11","author":"Massari","year":"2003","journal-title":"Trends Microbiol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.05.001_bib39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0264-410X(00)00324-8","article-title":"PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria","volume":"19","author":"Michaelsen","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1462-5822.2003.00257.x","article-title":"Neisserial PorB is translocated to the mitochondria of HeLa cells infected with Neisseria meningitidis and protects cells from apoptosis","volume":"5","author":"Massari","year":"2003","journal-title":"Cell Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib41","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/oxfordjournals.molbev.a003991","article-title":"Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB","volume":"19","author":"Urwin","year":"2002","journal-title":"Mol Biol Evol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.05.001_bib42","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"Arigita","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vaccine.2005.07.056","article-title":"Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis","volume":"24","author":"Humphries","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.001_bib44","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1365-2958.1999.01411.x","article-title":"Iron acquisition systems in the pathogenic Neisseria","volume":"32","author":"Schryvers","year":"1999","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-1119(93)90348-7","article-title":"Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2","volume":"130","author":"Legrain","year":"1993","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1099\/00222615-47-9-757","article-title":"Analysis of TbpA and TbpB functionality in defective mutants of Neisseria meningitidis","volume":"47","author":"Pintor","year":"1998","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/IAI.73.2.944-952.2005","article-title":"Meningococcal transferrin-binding proteins A and B show cooperation in their binding kinetics for human transferrin","volume":"73","author":"Stokes","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1574-6968.1993.tb06294.x","article-title":"Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features","volume":"110","author":"Rokbi","year":"1993","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib50","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/IAI.68.9.4938-4947.2000","article-title":"Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine","volume":"68","author":"Rokbi","year":"2000","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.05.001_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1574-6968.1990.tb04170.x","article-title":"Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis","volume":"69","author":"Griffiths","year":"1990","journal-title":"FEMS Microbiol Lett"},{"issue":"13","key":"10.1016\/j.vaccine.2009.05.001_bib52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0264-410X(95)00055-6","article-title":"Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential","volume":"13","author":"Gorringe","year":"1995","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.001_bib53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0264-410X(93)90045-Y","article-title":"Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals","volume":"11","author":"Danve","year":"1993","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(95)00136-O","article-title":"The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains","volume":"14","author":"Ala\u2019Aldeen","year":"1996","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib55","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.69.3.1561-1567.2001","article-title":"Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection","volume":"69","author":"West","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.001_bib56","series-title":"11th international pathogenic Neisseria conference","first-page":"53","article-title":"Safety and immunogenicity of a Neisseria meningitidis group B transferrin binding protein vaccine in adult","author":"Danve","year":"1998"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.vaccine.2006.08.001","article-title":"Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults","volume":"25","author":"Halperin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.001_bib58","series-title":"16th international pathogenic Neisseria conference","first-page":"270","article-title":"A randomized, observer-blinded, active control, phase 1 trial of meningococcal serogroup B rLP2086 vaccine in healthy children and adolescents aged 8 to 14 years","author":"Richmond","year":"2008"},{"key":"10.1016\/j.vaccine.2009.05.001_bib59","series-title":"16th international pathogenic Neisseria conference","first-page":"271","article-title":"A randomized, placebo-controlled, double-blind, phase 1 trial of ascending doses of meningococcal group B rLP2086 vaccine in healthy adults","author":"Marshall","year":"2008"},{"key":"10.1016\/j.vaccine.2009.05.001_bib60","series-title":"26th annual meeting of the european society for paediatric infectious diseases (ESPID)","article-title":"Safety and immunogenicity of Novartis meningoccocal serogroup B vaccine (MenB vaccine) after three doses administered in infancy","author":"Miller","year":"2008"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib61","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1128\/IAI.61.11.4724-4733.1993","article-title":"Molecular characterization of the 98-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis","volume":"61","author":"Pettersson","year":"1993","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1365-2958.1998.00707.x","article-title":"Molecular characterization of LbpB, the second lactoferrin-binding protein of Neisseria meningitidis","volume":"27","author":"Pettersson","year":"1998","journal-title":"Mol Microbiol"},{"issue":"17","key":"10.1016\/j.vaccine.2009.05.001_bib63","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.vaccine.2006.02.003","article-title":"Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB","volume":"24","author":"Pettersson","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib64","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JB.181.9.2895-2901.1999","article-title":"Ferric enterobactin binding and utilization by Neisseria gonorrhoeae","volume":"181","author":"Carson","year":"1999","journal-title":"J Bacteriol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib65","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/IAI.63.10.4181-4184.1995","article-title":"Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis","volume":"63","author":"Pettersson","year":"1995","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib66","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/IAI.58.9.3036-3041.1990","article-title":"Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific","volume":"58","author":"Pettersson","year":"1990","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib67","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1099\/13500872-142-11-3269","article-title":"Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae","volume":"142","author":"van der Ley","year":"1996","journal-title":"Microbiology"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib68","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"Thompson","year":"2003","journal-title":"Microbiology"},{"issue":"15","key":"10.1016\/j.vaccine.2009.05.001_bib69","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1128\/jb.178.15.4670-4678.1996","article-title":"HmbR outer membrane receptors of pathogenic Neisseria spp.: iron-regulated, hemoglobin-binding proteins with a high level of primary structure conservation","volume":"178","author":"Stojiljkovic","year":"1996","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2958.1995.tb02266.x","article-title":"The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence","volume":"15","author":"Stojiljkovic","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.001_bib71","doi-asserted-by":"crossref","unstructured":"Harrison OB, Evans NJ, Blair JM, Grimes HS, Tinsley CR, Nassif X, et al. Epidemiological evidence for the role of the haemoglobin receptor, HmbR, in meningococcal virulence. J Infect Dis; in press.","DOI":"10.1086\/599377"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2958.1997.2501619.x","article-title":"Molecular characterization of hpuAB, the haemoglobin\u2013haptoglobin utilization operon of Neisseria meningitidis","volume":"23","author":"Lewis","year":"1997","journal-title":"Mol Microbiol"},{"issue":"32","key":"10.1016\/j.vaccine.2009.05.001_bib73","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.vaccine.2005.03.015","article-title":"Identification of novel antigens that protect against systemic meningococcal infection","volume":"23","author":"Sun","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.001_bib74","series-title":"Handbook of meningococcal disease","first-page":"257","article-title":"Mechanisms of attachment and invasion","author":"Bourdoulous","year":"2006"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib75","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2958.2006.05261.x","article-title":"Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin","volume":"61","author":"Scarselli","year":"2006","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1574-695X.2000.tb01494.x","article-title":"Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis","volume":"28","author":"Peak","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib77","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1128\/IAI.00478-08","article-title":"Meningococcal outer membrane protein NhhA is essential for colonization and disease by preventing phagocytosis and complement attack","volume":"76","author":"Sjolinder","year":"2008","journal-title":"Infect Immun"},{"issue":"5459","key":"10.1016\/j.vaccine.2009.05.001_bib78","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-8244(01)00271-1","article-title":"In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters","volume":"32","author":"van Ulsen","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.001_bib80","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib81","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.2001.02516.x","article-title":"Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis","volume":"41","author":"Hadi","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.001_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2958.1994.tb01283.x","article-title":"A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells","volume":"14","author":"St Geme","year":"1994","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2958.2003.03420.x","article-title":"Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity","volume":"48","author":"Serruto","year":"2003","journal-title":"Mol Microbiol"},{"issue":"29","key":"10.1016\/j.vaccine.2009.05.001_bib84","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib85","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.resmic.2003.10.002","article-title":"The autotransporter secretion system","volume":"155","author":"Desvaux","year":"2004","journal-title":"Res Microbiol"},{"issue":"22","key":"10.1016\/j.vaccine.2009.05.001_bib87","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1093\/emboj\/19.22.5989","article-title":"Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesions","volume":"19","author":"Hoiczyk","year":"2000","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib88","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib89","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2958.2003.03678.x","article-title":"Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation","volume":"50","author":"Martin","year":"2003","journal-title":"Mol Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib90","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1073\/pnas.0406805102","article-title":"Microsatellite instability regulates transcription factor binding and gene expression","volume":"102","author":"Martin","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib91","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1099\/jmm.0.05017-0","article-title":"Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil","volume":"52","author":"Fukasawa","year":"2003","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib93","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00252-07","article-title":"Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci","volume":"15","author":"Norheim","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib94","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.179.6.3904","article-title":"IFN-\u03b3 and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A","volume":"179","author":"Mazzon","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib95","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1189\/jlb.1207810","article-title":"Human monocytes\/macrophages are a target of Neisseria meningitidis Adhesin A (NadA)","volume":"83","author":"Franzoso","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2958.1994.tb00416.x","article-title":"Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine","volume":"13","author":"Sarkari","year":"1994","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib97","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2958.1996.437970.x","article-title":"Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis","volume":"19","author":"Seiler","year":"1996","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib98","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2958.1999.01514.x","article-title":"The opcA and (psi)opcB regions in Neisseria: genes, pseudogenes, deletions, insertion elements and DNA islands","volume":"33","author":"Zhu","year":"1999","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib99","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2958.1993.tb00922.x","article-title":"Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells","volume":"10","author":"Virji","year":"1993","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2958.1994.tb01277.x","article-title":"Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells: the role of integrins in apical interactions","volume":"14","author":"Virji","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.001_bib101","doi-asserted-by":"crossref","unstructured":"Carbonnelle E, Morand P, Bourdoulous S, Nassif X, Hill DJ, Griffiths NJ, et al., Meningococcal interactions with the host, Vaccine 2009; this issue.","DOI":"10.1016\/j.vaccine.2009.04.069"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib102","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1462-5822.2008.01262.x","article-title":"Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin","volume":"11","author":"Cunha","year":"2008","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2958.1997.2051567.x","article-title":"Two-dimensional structure of the Opc invasin from Neisseria meningitidis","volume":"23","author":"Merker","year":"1997","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib104","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/IAI.69.6.3809-3816.2001","article-title":"Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci","volume":"69","author":"Jolley","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib105","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1046\/j.1365-2958.1996.01551.x","article-title":"Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae","volume":"22","author":"Virji","year":"1996","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib106","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2958.1999.01620.x","article-title":"Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules","volume":"34","author":"Virji","year":"1999","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2958.1996.01548.x","article-title":"The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae","volume":"22","author":"Virji","year":"1996","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.001_bib108","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/JB.180.5.1323-1330.1998","article-title":"Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins","volume":"180","author":"Malorny","year":"1998","journal-title":"J Bacteriol"},{"issue":"21","key":"10.1016\/j.vaccine.2009.05.001_bib109","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1046\/j.1432-1033.2002.03228.x","article-title":"Conformational analysis of opacity proteins from Neisseria meningitidis","volume":"269","author":"de Jonge","year":"2002","journal-title":"Eur J Biochem"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2958.1991.tb00789.x","article-title":"Characterization of the opa (class 5) gene family of Neisseria meningitidis","volume":"5","author":"Aho","year":"1991","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib111","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2958.1987.tb00520.x","article-title":"Common mechanism controlling phase and antigenic variation in pathogenic neisseriae","volume":"1","author":"Stern","year":"1987","journal-title":"Mol Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib112","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00293-06","article-title":"Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis","volume":"74","author":"Callaghan","year":"2006","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib113","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/JCM.00005-08","article-title":"Opa protein repertoires of disease-causing and carried meningococci","volume":"46","author":"Callaghan","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib114","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/IAI.40.1.398-406.1983","article-title":"Immunogenicity of meningococcal antigens as detected in patient sera","volume":"40","author":"Poolman","year":"1983","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib115","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1128\/IAI.57.5.1590-1598.1989","article-title":"Human immune response to meningococcal outer membrane epitopes after natural infection or vaccination","volume":"57","author":"Mandrell","year":"1989","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib116","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"Wedege","year":"1986","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/IAI.64.1.298-304.1996","article-title":"T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins","volume":"64","author":"Wiertz","year":"1996","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2958.1998.00910.x","article-title":"Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein","volume":"29","author":"Tonjum","year":"1998","journal-title":"Mol Microbiol"},{"issue":"38","key":"10.1016\/j.vaccine.2009.05.001_bib119","doi-asserted-by":"crossref","first-page":"39750","DOI":"10.1074\/jbc.M405971200","article-title":"Structure of the Neisseria meningitidis outer membrane PilQ secretin complex at 12 A resolution","volume":"279","author":"Collins","year":"2004","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.vaccine.2009.05.001_bib120","doi-asserted-by":"crossref","first-page":"18923","DOI":"10.1074\/jbc.M411603200","article-title":"Interaction with type IV pili induces structural changes in the bacterial outer membrane secretin PilQ","volume":"280","author":"Collins","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.05.001_bib121","series-title":"14th international pathogenic Neisseria conference","first-page":"161","article-title":"Immunisation with the meningococcal PilQ complex is protective in a mouse model of meningococcal disease and elicits bactericidal and opsonic antibodies","author":"Halliwell","year":"2004"},{"key":"10.1016\/j.vaccine.2009.05.001_bib122","series-title":"Handbook of meningococcal disease","first-page":"371","article-title":"Outer membrane vesicle-based meningococcal vaccines","author":"Poolman","year":"2006"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib123","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2009.05.001_bib124","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1074\/jbc.C800214200","article-title":"Solution structure of the factor H binding protein, a survival factor and protective antigen of Neisseria meningitidis","volume":"284","author":"Cantini","year":"2009","journal-title":"J Biol Chem"},{"issue":"7240","key":"10.1016\/j.vaccine.2009.05.001_bib125","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.vaccine.2009.05.001_bib126","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1074\/jbc.M808831200","article-title":"Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086","volume":"284","author":"Mascioni","year":"2008","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib127","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib128","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1074\/jbc.M508595200","article-title":"Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis","volume":"281","author":"Cantini","year":"2006","journal-title":"J Biol Chem"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.05.001_bib129","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.001_bib131","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib132","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","article-title":"Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37","volume":"77","author":"Seib","year":"2009","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.001_bib133","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.vaccine.2006.03.092","article-title":"Improved immunogenicity of a H44\/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870","volume":"25","author":"Koeberling","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.001_bib134","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","article-title":"Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection","volume":"185","author":"Martin","year":"1997","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib135","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/IAI.67.11.5664-5675.1999","article-title":"Differences in surface expression of NspA among Neisseria meningitidis group B strains","volume":"67","author":"Moe","year":"1999","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.001_bib136","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/IAI.69.6.3762-3771.2001","article-title":"Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B","volume":"69","author":"Moe","year":"2001","journal-title":"Infect Immun"},{"issue":"27","key":"10.1016\/j.vaccine.2009.05.001_bib137","doi-asserted-by":"crossref","first-page":"24825","DOI":"10.1074\/jbc.M302803200","article-title":"Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential","volume":"278","author":"Vandeputte-Rutten","year":"2003","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib138","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.05.001_bib139","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.micpath.2007.01.004","article-title":"A P60 mutant of Listeria monocytogenes is impaired in its ability to cause infection in intragastrically inoculated mice","volume":"42","author":"Faith","year":"2007","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.001_bib140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1099\/jmm.0.004820-0","article-title":"Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential","volume":"58","author":"Sardinas","year":"2009","journal-title":"J Med Microbiol"},{"issue":"50","key":"10.1016\/j.vaccine.2009.05.001_bib141","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1016\/j.vaccine.2007.09.053","article-title":"Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate","volume":"25","author":"Delgado","year":"2007","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2009.05.001_bib142","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1046\/j.1432-1033.2002.03064.x","article-title":"GNA33 from Neisseria meningitidis serogroup B encodes a membrane-bound lytic transglycosylase (MltA)","volume":"269","author":"Jennings","year":"2002","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.001_bib143","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/IAI.72.4.1914-1919.2004","article-title":"GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence","volume":"72","author":"Adu-Bobie","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib144","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.167.11.6487","article-title":"A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis","volume":"167","author":"Granoff","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/mpat.1998.0206","article-title":"Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87","volume":"25","author":"Manning","year":"1998","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.001_bib146","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1083\/jcb.200310092","article-title":"The Omp85 family of proteins is essential for outer membrane biogenesis in mitochondria and bacteria","volume":"164","author":"Gentle","year":"2004","journal-title":"J Cell Biol"},{"issue":"5604","key":"10.1016\/j.vaccine.2009.05.001_bib147","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1078973","article-title":"Role of a highly conserved bacterial protein in outer membrane protein assembly","volume":"299","author":"Voulhoux","year":"2003","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib148","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/IAI.00411-07","article-title":"Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis","volume":"75","author":"Weynants","year":"2007","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.001_bib149","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/81380","article-title":"Functional genomics of Neisseria meningitidis pathogenesis","volume":"6","author":"Sun","year":"2000","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.001_bib150","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1128\/IAI.73.9.5762-5766.2005","article-title":"Neisseria meningitidis lactate permease is required for nasopharyngeal colonization","volume":"73","author":"Exley","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.001_bib151","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/IAI.01530-06","article-title":"Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae","volume":"75","author":"Exley","year":"2007","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:47:09Z","timestamp":1589842029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":151,"alternative-id":["S0264410X09006665"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}